IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSNATI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.975
EU - Europa 7.708
AS - Asia 6.588
SA - Sud America 1.260
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 13
Totale 28.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.802
PL - Polonia 3.407
CN - Cina 2.309
SG - Singapore 2.228
UA - Ucraina 1.295
BR - Brasile 1.079
HK - Hong Kong 787
DE - Germania 740
IT - Italia 652
VN - Vietnam 432
FI - Finlandia 359
GB - Regno Unito 339
TR - Turchia 249
RU - Federazione Russa 226
IE - Irlanda 218
IN - India 183
FR - Francia 155
BD - Bangladesh 86
CA - Canada 79
ID - Indonesia 72
AR - Argentina 70
MX - Messico 61
NL - Olanda 58
ZA - Sudafrica 54
CZ - Repubblica Ceca 51
SE - Svezia 46
IQ - Iraq 38
AT - Austria 36
JP - Giappone 35
EC - Ecuador 34
ES - Italia 30
BE - Belgio 26
MA - Marocco 26
PK - Pakistan 26
IR - Iran 22
CO - Colombia 20
UZ - Uzbekistan 18
KE - Kenya 17
VE - Venezuela 16
CL - Cile 15
EU - Europa 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 12
AU - Australia 12
IL - Israele 11
JO - Giordania 11
LT - Lituania 11
EG - Egitto 10
JM - Giamaica 10
PE - Perù 10
MU - Mauritius 9
PA - Panama 8
PY - Paraguay 8
AZ - Azerbaigian 7
KZ - Kazakistan 7
PT - Portogallo 7
BG - Bulgaria 6
CH - Svizzera 6
DZ - Algeria 6
EE - Estonia 6
UY - Uruguay 6
KR - Corea 5
LB - Libano 5
LK - Sri Lanka 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LV - Lettonia 4
NO - Norvegia 4
SN - Senegal 4
TN - Tunisia 4
AL - Albania 3
HU - Ungheria 3
NP - Nepal 3
OM - Oman 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
IS - Islanda 2
MD - Moldavia 2
MY - Malesia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 28.682
Salva come PNG Salva come JPEG
Città #
Warsaw 3.400
Fairfield 1.667
Woodbridge 1.275
Ashburn 1.033
Jacksonville 956
Houston 894
Singapore 883
Hong Kong 784
Cambridge 711
Ann Arbor 605
Wilmington 599
Seattle 580
Beijing 545
Chandler 503
Princeton 397
Nanjing 348
Dallas 284
New York 268
Dublin 213
Los Angeles 201
Istanbul 183
Dearborn 154
Helsinki 153
The Dalles 140
Brescia 128
Nanchang 125
Dong Ket 122
Munich 114
Ho Chi Minh City 112
São Paulo 107
Buffalo 97
Moscow 97
San Francisco 87
San Diego 86
Milan 85
Des Moines 84
Shenyang 84
Jinan 79
Changsha 78
Hebei 74
Boardman 71
Hanoi 70
Redondo Beach 69
Chicago 66
Tianjin 66
Jiaxing 65
Lancaster 63
Shanghai 61
London 55
Brooklyn 47
Kunming 46
Jakarta 44
Hangzhou 42
Phoenix 42
Santa Clara 41
Verona 40
Rio de Janeiro 33
Tokyo 33
Augusta 32
Guangzhou 32
Rome 32
San Mateo 32
Belo Horizonte 30
Johannesburg 30
Toronto 30
Zhengzhou 29
Atlanta 28
Turku 28
Brno 27
Haikou 27
Lanzhou 27
Nuremberg 27
Leawood 25
Ningbo 25
Denver 24
Kocaeli 24
Brussels 23
Norwalk 22
Olomouc 21
Poplar 21
Mexico City 20
Montreal 20
Dhaka 19
Orem 19
Taizhou 19
Brasília 18
Changchun 18
Parma 18
Boston 17
Council Bluffs 17
Curitiba 17
Fuzhou 17
Manchester 17
Salt Lake City 17
Stockholm 17
Taiyuan 17
Ankara 16
Charlotte 16
Chennai 16
Monmouth Junction 16
Totale 20.236
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 338
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 298
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 293
Biological role of immunoglobulin Free light chains interactomes 289
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 284
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 279
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures. 278
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 270
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 270
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 262
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 261
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 259
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 256
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 252
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 250
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 249
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 248
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 245
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 244
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 243
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 232
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 232
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 225
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 224
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 222
The FGF2-binding domain of thrombospondin-1: functional characterization and exploitation to design antiangiogenic compounds 222
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 212
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 210
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 210
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 197
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 197
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 197
Chemoselective surface immbolization of proteins through a cleavable peptide 196
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 193
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 191
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 186
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 183
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 180
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 179
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 179
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 177
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 174
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 173
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 173
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 169
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 167
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 166
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 165
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 163
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 161
Sialic acid as a target for the development of novel antiangiogenic strategies 161
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 159
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 158
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 158
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 157
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 153
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 153
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 151
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 148
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 147
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 145
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 145
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 144
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 144
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 143
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 142
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 141
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 138
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 136
The colloidal side of cell communication. 135
Liver DNA damage by chemical carcinogens: role of thyroid hormones 133
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 132
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 132
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 131
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 130
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 130
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 129
Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. 129
Biochemical bases of the interaction of the human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies 128
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 128
Heparin derivatives as angiogenesis inhibitors 127
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 127
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 127
Targeting fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis 125
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 125
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 125
Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cells. 125
Fibroblast growth factor-2 in angiogenesis 122
Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans 122
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 122
The Impact of Surface Plasmon Resonance in Virology 122
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. 121
Multispot, label-free biodetection at a phantom plastic-water interface. 121
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. 120
Dendritic cell-endothelial cell cross-talk in angiogenesis. 120
A monoclonal antibody to the NH2-terminal region of HuIFN inhibits the antiproliferative activity of the lymphokine without affecting its internalization 120
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 120
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 119
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. 119
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 119
Totale 17.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.316 0 0 0 0 0 394 136 423 458 280 409 216
2021/20221.785 93 423 30 43 24 69 123 119 84 235 141 401
2022/20231.409 219 59 56 93 106 382 9 149 198 18 48 72
2023/20241.549 93 30 137 68 67 235 52 69 403 49 40 306
2024/20253.988 47 23 18 493 356 286 279 125 350 461 948 602
2025/20265.051 824 1.167 829 1.315 805 111 0 0 0 0 0 0
Totale 29.125